QurCan Therapeutics Inc.
Azhar Zahoor Abbasi is an experienced Executive Vice President leading R&D activities at QurCan Therapeutics Inc. Azhar Zahoor has a background in Pharmaceutical R&D, with roles at companies like Apotex Inc. and University of Toronto as a Senior Scientist and Postdoctoral Research Fellow. With a PhD in Polymer Science, Nanotechnology, and Biophotonics from The Philipp University of Marburg, Azhar has a strong research background and a track record of impactful publications and conference presentations.
This person is not in any teams
QurCan Therapeutics Inc.
Nanology Labs has designed and is developing Manganescan®, a novel theranostic agent (MRI contrast agent/Radio-sensitizer) that allows detection of brain tumors at early stages using MRI. Simultaneously, it sensitizes cancer cells which improves radiation therapy outcomes. The agent is 3x more sensitive than current Gadolinium contrast agents(GBCAs), can cross the blood brain barrier and enables early and precise detection and targeting of brain cancer.